vs
Side-by-side financial comparison of INTELLIGENT PROTECTION MANAGEMENT CORP. (IPM) and Sunshine Biopharma Inc. (SBFM). Click either name above to swap in a different company.
Sunshine Biopharma Inc. is the larger business by last-quarter revenue ($8.6M vs $6.1M, roughly 1.4× INTELLIGENT PROTECTION MANAGEMENT CORP.). On growth, INTELLIGENT PROTECTION MANAGEMENT CORP. posted the faster year-over-year revenue change (2091.6% vs -10.6%). Over the past eight quarters, INTELLIGENT PROTECTION MANAGEMENT CORP.'s revenue compounded faster (54.7% CAGR vs 6.6%).
Intelligent Limited is a Holding Company and Parent company headquartered in Gloucestershire, United Kingdom and was incorporated on 21 May 2008. Intelligent Limited provides a group management structure for four companies and was born out of the operations of International Intelligence Limited, a company specialising in Intelligence, Counter Espionage and TSCM sweeping.
Sunshine Biopharma Inc. is a clinical-stage biopharmaceutical company focused on researching, developing and commercializing innovative therapies for oncology, neurodegenerative disorders and infectious diseases. It targets unmet medical needs across global markets, with a pipeline of targeted therapeutic candidates designed to improve patient treatment outcomes.
IPM vs SBFM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $6.1M | $8.6M |
| Net Profit | — | $-2.1M |
| Gross Margin | 53.1% | 35.3% |
| Operating Margin | -13.4% | -20.9% |
| Net Margin | — | -25.0% |
| Revenue YoY | 2091.6% | -10.6% |
| Net Profit YoY | — | 0.8% |
| EPS (diluted) | $-0.05 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $6.1M | $8.6M | ||
| Q3 25 | $6.2M | $9.4M | ||
| Q2 25 | $5.7M | $9.4M | ||
| Q1 25 | $5.5M | $8.9M | ||
| Q4 24 | — | $9.6M | ||
| Q3 24 | — | $8.4M | ||
| Q2 24 | — | $9.3M | ||
| Q1 24 | — | $7.5M |
| Q4 25 | — | $-2.1M | ||
| Q3 25 | $-1.1M | $-883.8K | ||
| Q2 25 | $-1.1M | $-1.8M | ||
| Q1 25 | $808.5K | $-1.2M | ||
| Q4 24 | — | $-2.2M | ||
| Q3 24 | — | $-1.2M | ||
| Q2 24 | — | $-494.3K | ||
| Q1 24 | — | $-1.3M |
| Q4 25 | 53.1% | 35.3% | ||
| Q3 25 | 50.7% | 32.6% | ||
| Q2 25 | 50.1% | 36.4% | ||
| Q1 25 | 55.3% | 30.7% | ||
| Q4 24 | — | 32.2% | ||
| Q3 24 | — | 34.0% | ||
| Q2 24 | — | 25.3% | ||
| Q1 24 | — | 31.2% |
| Q4 25 | -13.4% | -20.9% | ||
| Q3 25 | -23.0% | -11.5% | ||
| Q2 25 | -19.7% | -21.8% | ||
| Q1 25 | -24.2% | -14.6% | ||
| Q4 24 | — | -21.7% | ||
| Q3 24 | — | -13.1% | ||
| Q2 24 | — | -13.6% | ||
| Q1 24 | — | -17.9% |
| Q4 25 | — | -25.0% | ||
| Q3 25 | -17.4% | -9.4% | ||
| Q2 25 | -18.3% | -18.8% | ||
| Q1 25 | 14.7% | -13.3% | ||
| Q4 24 | — | -22.5% | ||
| Q3 24 | — | -14.2% | ||
| Q2 24 | — | -5.3% | ||
| Q1 24 | — | -17.0% |
| Q4 25 | $-0.05 | — | ||
| Q3 25 | $-0.08 | $-0.54 | ||
| Q2 25 | $-0.08 | $-0.82 | ||
| Q1 25 | $0.06 | $-0.44 | ||
| Q4 24 | — | $49.77 | ||
| Q3 24 | — | $-11.61 | ||
| Q2 24 | — | $-43.48 | ||
| Q1 24 | — | $-2.00 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $5.6M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $18.2M | $23.0M |
| Total Assets | $26.0M | $30.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.6M | — | ||
| Q3 25 | $7.3M | — | ||
| Q2 25 | $7.3M | — | ||
| Q1 25 | $9.7M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $18.2M | $23.0M | ||
| Q3 25 | $18.8M | $24.2M | ||
| Q2 25 | $19.9M | $25.7M | ||
| Q1 25 | $21.1M | $22.7M | ||
| Q4 24 | — | $23.5M | ||
| Q3 24 | — | $25.0M | ||
| Q2 24 | — | $23.5M | ||
| Q1 24 | — | $24.8M |
| Q4 25 | $26.0M | $30.1M | ||
| Q3 25 | $27.2M | $31.5M | ||
| Q2 25 | $29.8M | $32.0M | ||
| Q1 25 | $31.1M | $29.2M | ||
| Q4 24 | — | $30.6M | ||
| Q3 24 | — | $30.1M | ||
| Q2 24 | — | $29.3M | ||
| Q1 24 | — | $31.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $87.6K | $-1.6M |
| Free Cash FlowOCF − Capex | — | $-1.6M |
| FCF MarginFCF / Revenue | — | -18.9% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-5.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $87.6K | $-1.6M | ||
| Q3 25 | $133.0K | $-727.8K | ||
| Q2 25 | $-888.7K | $-1.3M | ||
| Q1 25 | $1.7M | $-1.7M | ||
| Q4 24 | — | $-3.4M | ||
| Q3 24 | — | $-1.4M | ||
| Q2 24 | — | $-4.6M | ||
| Q1 24 | — | $-3.2M |
| Q4 25 | — | $-1.6M | ||
| Q3 25 | — | $-735.8K | ||
| Q2 25 | — | $-1.4M | ||
| Q1 25 | — | $-1.7M | ||
| Q4 24 | — | $-3.5M | ||
| Q3 24 | — | $-1.9M | ||
| Q2 24 | — | $-5.6M | ||
| Q1 24 | — | $-3.2M |
| Q4 25 | — | -18.9% | ||
| Q3 25 | — | -7.8% | ||
| Q2 25 | — | -15.2% | ||
| Q1 25 | — | -19.3% | ||
| Q4 24 | — | -36.6% | ||
| Q3 24 | — | -22.2% | ||
| Q2 24 | — | -59.7% | ||
| Q1 24 | — | -43.1% |
| Q4 25 | — | 0.0% | ||
| Q3 25 | 0.0% | 0.1% | ||
| Q2 25 | — | 1.7% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 1.1% | ||
| Q3 24 | — | 6.1% | ||
| Q2 24 | — | 10.5% | ||
| Q1 24 | — | 0.8% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 2.16× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IPM
| Procurement Revenue | $5.4M | 88% |
| Other | $743.9K | 12% |
SBFM
Segment breakdown not available.
